Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse

Modern Pathology

Volumn 19, Issue 5, 2006, Pages 648-658

  Al Mulla, Fahd ^a   Behbehani, Abdulla I ^a   Bitar, Milad S ^a   Varadharaj, Govindarajulu ^a   Going, James J ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

CGH; Colorectal cancer; Dukes' stage I; Dukes' stage II; Microarray CGH

Indexed keywords

DNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

AGED; CHROMOSOME ABERRATIONS; COLORECTAL NEOPLASMS; FEMALE; GENOME, HUMAN; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33646151165     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800564     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Hermanek P. pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg 1995;19:184-190.
3. Bardi G, Fenger C, Johansson B, et al. Tumor karyotype predicts clinical outcome in colorectal cancer patients. J Clin Oncol 2004;22:2623-2634.
4. De Angelis PM, Stokke T, Beigi M, et al. Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer. Int J Colorectal Dis 2001;16:38-45.
5. Diep CB, Thorstensen L, Meling GI, et al. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients. J Clin Oncol 2003;21:820-829.
6. Choi SW, Lee KJ, Bae YA, et al. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res 2002;8:2311-2322.
7. Martinez-Lopez E, Abad A, Font A, et al. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 1998;114:1180-1187.
8. Zhou W, Goodman SN, Galizia G, et al. Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet 2002;359:219-225.
9. Al-Mulla F, Going JJ, Sowden ET, et al. Heterogeneity of mutant vs wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol 1998;185:130-138.
10. Al-Mulla F, Keith WN, Pickford IR, et al. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer 1999;24:306-314.
11. Ried T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996;15:234-245.
12. Nakao K, Shibusawa M, Ishihara A, et al. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy. Cancer 2001;91:721-726.
13. De Angelis PM, Clausen OP, Schjolberg A, et al. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer 1999;80:526-535.
14. Thorstensen L, Qvist H, Heim S, et al. Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients. Neoplasia 2000;2:514-522.
15. Ogunbiyi OA, Goodfellow PJ, Gagliardi G, et al. Prognostic value of chromosome 1p allelic loss in colon cancer. Gastroenterology 1997;113:761-766.
16. Bardi G, Sukhikh T, Pandis N, et al. Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer 1995;12:97-109.
17. Arribas R, Ribas M, Risques RA, et al. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival. Clin Cancer Res 1999;5:3454-3459.
18. Halling KC, French AJ, McDonnell SK, et al. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 1999;91:1295-1303.
19. Kelemen PR, Yaremko ML, Kim AH, et al. Loss of heterozygosity in 8p is associated with microinvasion in colorectal carcinoma. Genes Chromosomes Cancer 1994;11:195-198.
20. Kochhar R, Halling KC, McDonnell S, et al. Allelic imbalance and microsatellite instability in resected Duke's D colorectal cancer. Diagn Mol Pathol 1997;6:78-84.
21. Weber TK, Conroy J, Keitz B, et al. Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer. Cytogenet Cell Genet 1999;86:142-147.
22. Bando T, Kato Y, Ihara Y, et al. Loss of heterozygosity of 14q32 in colorectal carcinoma. Cancer Genet Cytogenet 1999;111:161-165.
23. Korn WM, Yasutake T, Kuo WL, et al. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 1999;25:82-90.
24. Hayes DF, Trock B, Harris AL. Assessing the clinical impact of prognostic factors: when is 'statistically significant' clinically useful? Breast Cancer Res Treat 1998;52:305-319.